|
PUM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.27380000675737E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.7148954719396E-11 |
| Normal-vs-Stage2 |
2.30609999996023E-06 |
| Normal-vs-Stage3 |
8.52320436450782E-11 |
| Normal-vs-Stage4 |
4.64279947820501E-10 |
| Stage1-vs-Stage2 |
7.544600E-01 |
| Stage1-vs-Stage3 |
9.977700E-02 |
| Stage1-vs-Stage4 |
1.551690E-02 |
| Stage2-vs-Stage3 |
4.173000E-01 |
| Stage2-vs-Stage4 |
1.542390E-01 |
| Stage3-vs-Stage4 |
4.432600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.7629999944121E-09 |
| Normal-vs-AfricanAmerican |
2.224800E-03 |
| Normal-vs-Asian |
2.69020000054354E-07 |
| Caucasian-vs-AfricanAmerican |
2.673600E-01 |
| Caucasian-vs-Asian |
7.571400E-01 |
| AfricanAmerican-vs-Asian |
4.774200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62119999647103E-08 |
| Normal-vs-Female |
4.38250002954277E-09 |
| Male-vs-Female |
3.299800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.64969998667419E-09 |
| Normal-vs-Age(41-60Yrs) |
1.00960351190338E-11 |
| Normal-vs-Age(61-80Yrs) |
6.48589959517665E-10 |
| Normal-vs-Age(81-100Yrs) |
4.102600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.118400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.444800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.337200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.102600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.201400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.490400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.788100E-02 |
| Classical-VS-Follicular |
4.006800E-01 |
| Classical-VS-Other |
6.354400E-01 |
| Classical-VS-Normal |
2.43520000053898E-07 |
| Tall-VS-Follicular |
2.517200E-01 |
| Tall-VS-Other |
1.703010E-01 |
| Tall-VS-Normal |
2.23370000274059E-08 |
| Follicular-VS-Other |
5.134600E-01 |
| Follicular-VS-Normal |
7.31870000159063E-08 |
| Other-VS-Normal |
7.867700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.30284671939762E-12 |
| Normal-vs-N1 |
5.30489996375394E-09 |
| N0-vs-N1 |
4.848000E-01 |
|
|
